• Home
  • About Us
    • Who Are We ?

    • Vision & Mission

    • Promoters
  • Manufacturing Sites
    • BLL (WHO-GMP) ------

    • Brooks Steriscience
  • Our Products
    • General Products   
      • Liquid Injection Ampoules

      • Liquid Injection Vials

      • Dry Powder Injection Vials

      • Lyophilized Injections

      • Eye/Ear Drops

      • Nasal Drops

    • β-Lactam Range  
      • Tablets

      • Dry Powder Syrup

      • Injection

    • Cephalosporin Range  
      • Tablets

      • Dry Powder Syrup

      • Injection
  • Sales & Marketing
    • India  
      • CCD

      • Institutional Business

      • CDMO Services

    • International  
      • Our Global Presence
  • Investors
    • Investors Forum

    • Committee Details
  • Contact Us
    • Product Enquiry

    • Investor Enquiry

    • Career Enquiry

Annual Return

Details of Business Disclaimer Financial Results Annual Report Annual Return MOA AOA Preferential Allotment List of Directors Shareholding Pattern Newspaper Advertisements Policies Notices Voting Results Disclosure Under Regulation-30 Secreterial Compliance Report Annual Reports of Subsidiary Companies Related Party Transaction Investors Contact Investor Forms Right Issue Prospectus Credit Rating

Annual Return

  • Annual Return 2023-2024
  • Annual Return 2022-2023
  • Annual Return 2021-2022
  • Annual Return 2020-2021
  • Annual Return 2019-2020
  • BSE Code - 533543
  • NSE Symbol - BROOKS
  • With roots dating back to 2002, Brooks Laboratories were established with a sole purpose of being a pioneer in the Pharmaceutical industry.
News & Articles
  • Events
Useful Links
  • Policy
  • Annual Reports
  • BLL(WHO-GMP)
  • Brooks Steriscience
Reach Us

Copyright © 2025 Brooks Laboratories. All right reserved. Designed by Sharptech Company